Literature DB >> 6455296

Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer.

R W Talley, M K Samson, R W Brownlee, A M Samhouri, R J Fraile, L H Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6455296     DOI： 10.1016/0014-2964(81)90125-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Synthesis and antineoplastic activity of CNC-cysteamine and related compounds.

Authors:  W C Tang; J Schmid; H H Fiebig; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma.

Authors:  D A Amato; E C Borden; M Shiraki; H T Enterline; C Rosenbaum; H L Davis; A R Paul; C M Stevens; H J Lerner
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.